Literature DB >> 1652023

Synthesis and dopaminergic activity of 3-substituted 1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-1H-2-benzopyrans: characterization of an auxiliary binding region in the D1 receptor.

M P DeNinno1, R Schoenleber, R J Perner, L Lijewski, K E Asin, D R Britton, R MacKenzie, J W Kebabian.   

Abstract

The synthesis and dopaminergic activity of a series of C3 and nitrogen-substituted 1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-1H-2-benzopyrans (isochromans) is described. The synthesis of the compounds was stereospecific for the 1,3 cis isomer, and the enantioselective synthesis of both enantiomers of one of the analogues (20) was achieved. It was determined that all of the dopaminergic activity resides in the [1R,3S] isomer. Generally, substitution at the C3 position provided compounds with very high potency (less than 10 nm EC50) and selectivity for the D1 receptor, with a wide range of intrinsic activities (60-160%). Analogues containing C3 substituents including aryl, arylalkyl, and cyclic and acyclic alkyl groups showed a marked enhancement of dopaminergic activity compared to the unsubstituted compound. As a class, the drugs were orally active in the rat rotation model with a very long duration of action.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652023     DOI: 10.1021/jm00112a034

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Facile synthesis of octahydrobenzo[h]isoquinolines: novel and highly potent D1 dopamine agonists.

Authors:  Lisa A Bonner; Benjamin R Chemel; Val J Watts; David E Nichols
Journal:  Bioorg Med Chem       Date:  2010-07-27       Impact factor: 3.641

2.  Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptors.

Authors:  Jessica P Ryman-Rasmussen; Adam Griffith; Scott Oloff; Nagarajan Vaidehi; Justin T Brown; William A Goddard; Richard B Mailman
Journal:  Neuropharmacology       Date:  2006-10-24       Impact factor: 5.250

Review 3.  Brain dopamine receptors: 20 years of progress.

Authors:  J W Kebabian
Journal:  Neurochem Res       Date:  1993-01       Impact factor: 3.996

4.  Mapping the catechol binding site in dopamine D₁ receptors: synthesis and evaluation of two parallel series of bicyclic dopamine analogues.

Authors:  Lisa A Bonner; Uros Laban; Benjamin R Chemel; Jose I Juncosa; Markus A Lill; Val J Watts; David E Nichols
Journal:  ChemMedChem       Date:  2011-04-28       Impact factor: 3.466

5.  Ligand-specific roles for transmembrane 5 serine residues in the binding and efficacy of dopamine D(1) receptor catechol agonists.

Authors:  Benjamin R Chemel; Lisa A Bonner; Val J Watts; David E Nichols
Journal:  Mol Pharmacol       Date:  2012-02-14       Impact factor: 4.436

Review 6.  Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors.

Authors:  Jaromir Myslivecek
Journal:  Life (Basel)       Date:  2022-04-19

7.  Biomimetic synthesis of the tetracyclic core of berkelic acid.

Authors:  Jingye Zhou; Barry B Snider
Journal:  Org Lett       Date:  2007-04-28       Impact factor: 6.005

8.  Cell signaling underlying epileptic behavior.

Authors:  Yuri Bozzi; Mark Dunleavy; David C Henshall
Journal:  Front Behav Neurosci       Date:  2011-08-02       Impact factor: 3.558

Review 9.  The Discovery of Novel Selective D1 Dopaminergic Agonists: A-68930, A-77636, A-86929, and ABT-413.

Authors:  Yvonne Connolly Martin
Journal:  Int J Med Chem       Date:  2011-03-24

10.  The role of dopamine signaling in epileptogenesis.

Authors:  Yuri Bozzi; Emiliana Borrelli
Journal:  Front Cell Neurosci       Date:  2013-09-17       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.